Delivery Order SPE2DB22D2009-SPE2DB25FM1GT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,744.20 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count) on September 11, 2025, with completion targeted for September 12, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single-line pharmaceutical product delivery under the...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Chloraseptic Max 15-10 mg lozenges in quantities of 15 units. This is a firm fixed-price delivery order with a ceiling value of $2,636.76 and an ultimate completion date of August 18, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Chloraseptic Max 15-10 mg lozenges (15-count packages) with a ceiling value of $3,021.03. This competitively awarded, non-set-aside contract employs firm fixed price pricing and is scheduled for completion by September 16, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing this work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Chloraseptic Max 15-10 mg lozenges (15-count) under a firm fixed-price contract valued at $3,864.64, with an ultimate completion date of September 18, 2025. This non-set-aside award was issued competitively and represents a single delivery order for over-the-counter throat lozenges to support federal medical supply needs. The contract was performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,707.30 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count packages). Issued on August 6, 2025, with an ultimate completion date of August 7, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a $1,290.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count packages) on June 2, 2025, with an ultimate completion date of June 3, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,855.84 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18 count) on July 15, 2025, with completion scheduled for July 16, 2025. This firm fixed price contract, which received no set-aside designation, was competitively awarded and performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,119.84 for Chloraseptic sore throat lozenges (18-count). This firm fixed-price contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a routine pharmaceutical supply delivery under the company's broader federal medical procurement relationship. The order will be performed in Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Chloraseptic Max 15-10 mg Lozenges. The $2,054.66 firm-fixed-price contract has an ultimate completion date of August 7, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which serves as the primary vehicle for providing a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $3,452.36 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 19, 2025, for Chloraseptic Sore 18s products. This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM1GTDelivery Order
The Defense Logistics Agency awarded a $5,290.15 delivery order to AmerisourceBergen Drug Corp for Chloraseptic Max 15-10 mg lozenges (15 count) on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's critical role in supplying pharmaceutical products and medical supplies to federal healthcare systems. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle extending through December 2026. The parent IDC enables the company to supply a wide range of pharmaceuticals, medical devices, and healthcare commodities to support military and federal healthcare programs globally. AmerisourceBergen maintains a substantial presence as a prime pharmaceutical vendor for federal medical procurement, consistently competing successfully for open market delivery orders across multiple therapeutic categories while serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 9/3/25 |